AGA Medical heart defect repair tool:
This article was originally published in Clinica
AGA Medical claims it has become the first firm to gain Japanese approval for a transcatheter occlusion device for repairing an atrial septal defect (ASD), an opening in the heart's septum. The Amplatzer septal occluder consists of a minimally invasive, catheter-based device that is delivered via a vessel to the heart, where it serves to clamp shut the septum opening. Already marketed in over 90 countries worldwide, including the US, the product provides an alternative to open heart surgery. The Minneapolis, Minnesota firm is one of several companies making transcatheter occlusion devices.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.